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Acute Downregulation of ENaC by EGF Involves the PY Motif 
and Putative ERK Phosphorylation Site
Rebecca A. Falin1 and Calvin U. Cotton1,2
1Department of Physiology and Biophysics and 2Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106
The epithelial sodium channel (ENaC) is expressed in a variety of tissues, including the renal collecting duct, 
where it constitutes the rate-limiting step for sodium reabsorption. Liddle’s syndrome is caused by gain-of-function 
mutations in the β and γ subunits of ENaC, resulting in enhanced Na reabsorption and hypertension. Epidermal 
growth factor (EGF) causes acute inhibition of Na absorption in collecting duct principal cells via an extracellular 
signal–regulated kinase (ERK)–dependent mechanism. In experiments with primary cultures of collecting duct 
cells derived from a mouse model of Liddle’s disease (β-ENaC truncation), it was found that EGF inhibited short-
circuit current (Isc) by 24 ± 5% in wild-type cells but only by 6 ± 3% in homozygous mutant cells. In order to elu-
cidate the role of specifi  c regions of the β-ENaC C terminus, Madin-Darby canine kidney (MDCK) cell lines that 
express β-ENaC with mutation of the PY motif (P616L), the ERK phosphorylation site (T613A), and C terminus 
truncation (R564stop) were created using the Phoenix retroviral system. All three mutants exhibited signifi  cant 
attenuation of the EGF-induced inhibition of sodium current. In MDCK cells with wild-type β-ENaC, EGF-induced 
inhibition of Isc (<30 min) was fully reversed by exposure to an ERK kinase inhibitor and occurred with no change 
in ENaC surface expression, indicative of an effect on channel open probability (Po). At later times (>30 min), 
EGF-induced inhibition of Isc was not reversed by an ERK kinase inhibitor and was accompanied by a decrease in 
ENaC surface expression. Our results are consistent with an ERK-mediated decrease in ENaC open probability and 
enhanced retrieval of sodium channels from the apical membrane.
INTRODUCTION
The epithelial sodium channel is found in the apical 
membrane of a number of epithelial tissues, including 
the renal tubule, airway epithelia, lining of the distal 
colon, and ducts of the exocrine glands. It is the rate-
limiting step in the process of sodium reabsorption and 
is important for maintaining electrolyte and water bal-
ance and, thereby, blood pressure (Garty and Palmer, 
1997). The channel consists of three subunits, α, β, and 
γ, each of which contains two membrane-spanning 
domains with intracellular N and C termini and a con-
served cysteine-rich region in the extracellular loop. 
These characteristics are shared with Caenorhabditis 
elegans degenerins and other members of the DEG/ENaC 
superfamily (Lingueglia et al., 1993; Renard et al., 
1994; Rotin et al., 1994; Snyder, 1994; Voilley et al., 
1994, 1997). The stoichiometry of the active channel is 
generally thought to be 2α:1β:1γ, although other com-
binations have been proposed (Snyder et al., 1998; 
Rossier et al., 2002; Staruschenko et al., 2005). All three 
subunits also contain a conserved PY motif (PPXY) in 
their C terminus and lysines on their N terminus (Chen 
and Sudol, 1995). The α and γ subunits are proteolyti-
cally cleaved during maturation and/or after delivery 
to the plasma membrane, resulting in channel activa-
tion (Hughey et al., 2003; Sheng et al., 2006; Bruns 
et al., 2007).
The main physiological regulator of Na+ reabsorption 
in the renal collecting duct is the steroid hormone 
  aldosterone, which binds to mineralocorticoid receptor 
and is known to induce the transcription of a number 
of genes, including the α-subunit of ENaC, resulting 
in long-term increases in Na+ transport (Schafer, 2002). 
Insulin and vasopressin also increase Na+ transport 
in the collecting duct (Blazer-Yost et al., 1998; Morris 
and Schafer, 2002). The mechanisms responsible for in-
creased sodium transport in epithelial cells are not fully 
understood, but increases in the number of active chan-
nels and/or channel open probability have been pro-
posed (Rossier, 2002). The number of channels in the 
plasma membrane is determined by the rates of chan-
nel insertion and retrieval. The PY motifs, located in the 
intracellular C termini of the β- and γ-ENaC subunits, 
have been shown to play key role in removal of channels. 
The protein ubiquitin ligase Nedd4 contains trypto-
phan-rich WW domains, which bind to the PY motif 
on the β and γ subunits of ENaC (Staub et al., 1996). 
Nedd4 in turn polyubiquitinates ENaC on lysine resi-
dues on the N terminus and targets the channel for 
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internalization and degradation (Staub et al., 1997, 2000). 
The study of Liddle’s syndrome has been instrumental 
in our understanding of this regulatory process. Liddle’s 
syndrome is caused by one of a number of gain-of-
function mutations in the β- or γ-subunit of ENaC that 
either abrogate most of the C terminus or disrupt the 
PY motif (Warnock, 2001; Hummler, 2003). Quantitative 
studies of channel function and surface expression sug-
gested dual effects of Liddle’s mutations on channel 
number and channel open probability (Firsov et al., 
1996). The results of a recent study (Knight et al., 2006) 
suggest that Liddle’s mutations increase ENaC expression 
in the plasma membrane as well as the fraction of cleaved, 
fully active channels.
Epidermal growth factor (EGF) is a potent activator of 
the extracellular signal–regulated kinases (ERK) in wide 
range of mammalian cells. ERK1 and ERK2, collectively 
referred to as ERK1/2, are members of the mitogen-
  activated protein kinase (MAPK) signaling cascade that 
translates external signals into intracellular responses 
(Cano and Mahadevan, 1995; Cobb, 1999; Pearson 
et al., 2001). EGF-induced activation of the ERK signal-
ing cascade has been implicated in a variety of cellular 
functions, including cell migration, cell cycle progres-
sion, and differentiation (Kari et al., 2003). EGF modu-
lates Na+ transport in epithelial cells in a several ways. It 
stimulates transport through the Na+-K+-ATPase, but re-
duces the expression of ENaC mRNA in alveolar type II 
cells (Danto et al., 1998). In mouse renal collecting duct 
cells, EGF rapidly inhibits amiloride-sensitive sodium 
current in an ERK1/2-dependent manner and long-
term exposure to EGF reduces ENaC mRNA expression 
(Shen and Cotton, 2003; Falin et al., 2005).
Protein phosphorylation/dephosphorylation is an 
important posttranslational modifi  cation implicated in 
a wide variety of regulatory functions. Increased phos-
phorylation of β- and γ-ENaC subunits in response to in-
sulin was associated with an increase in channel function 
in A6 cells (Zhang et al., 2005). Three phosphorylation 
sites have been identifi  ed in the C-terminal tail of the 
β (and γ)-ENaC subunit. βS613 is phosphorylated by 
casein kinase 2 (Shi et al., 2002b), but the functional con-
sequence of phosphorylation at this site has not been 
determined. The second site is at βS620 (γT630), and 
phosphorylation of this site has been linked with the 
serum glucocorticoid kinase (sgk)–related increase in 
channel activity (Chigaev et al., 2001). The third site is a 
putative ERK1/2 phosphorylation site located at βT613 
(γT623), adjacent to the PY motif. Phosphorylation of 
this site has been shown to increase the association rate 
constant for the ENaC C terminus and the WW domain 
of the protein ubiquitin ligase Nedd4-2 (Shi et al., 2002a) 
and has been implicated in cAMP-dependent regulation 
of ENaC (Yang et al., 2006). The purpose of this study is 
to determine the role of the β-ENaC PY motif and puta-
tive ERK phosphorylation site in EGF-induced inhibition 
of sodium absorption in mammalian renal epithelial cells. 
We found that the acute inhibitory response to EGF was 
impaired by β-ENaC truncation and by point mutations 
in the PY motif and putative ERK phosphorylation site 
and that inhibition is due to sequential effects on chan-
nel activity and surface expression.
MATERIALS AND METHODS
Cell Culture
Madin-Darby canine kidney (MDCK) cells were maintained in 
growth media (GM), consisting of a 1:1 mixture of Dulbecco’s 
modifi  ed Eagle’s medium and Ham’s F-12 medium and supple-
mented with 10% FBS, 2.5 mM l-glutamine, 50 U/ml penicillin, 
and 50 mg/ml streptomycin. ENaC expression was induced by 
growing of cells in induction media (IM) for 48 h. IM is serum-
free GM that is supplemented with 1 μM dexamethasone and 
2 mM sodium butyrate. The rationale for using serum-free media 
during the 48-h induction period is that inclusion of 10% serum 
caused nearly maximal ERK1/2 phosphorylation in these cells 
and limited our ability to acutely stimulate ERK1/2 phosphoryla-
tion with exogenous EGF. Cells were grown at 37°C with 5% CO2 
and passaged every 3–5 d.
Primary renal cells were obtained from freshly excised kidneys 
(Veizis et al., 2004; Falin et al., 2005). Kidneys were removed under 
sterile conditions from CO2-anesthesized mice between the ages of 
16 and 21 d. The renal capsule was peeled away and kidneys minced 
with a razor blade and rinsed in PBS. Samples were centrifuged at 
20 g for 3 min and the PBS removed. The kidney tissue was then 
suspended in a solution of CT media containing 0.65 mg/ml 
Type IV collagenase and digested for 10–15 min in a 37°C water bath. 
Samples were again centrifuged and the media removed. Fresh CT 
media was added and digested tissue was resuspended and then 
plated onto plastic culture dishes. Media was changed every 48 h, 
for 6–8 d before sorting. In preparation for sorting, cells were de-
tached from the plates with 0.25% trypsin in 0.5 mM EDTA, sus-
pended in DMEM containing 10% FBS, and fi  ltered  through 
40-μm mesh. Cells were centrifuged at 100 g for 5 min and the pel-
let resuspended in ice-cold PBS plus glucose, fi  ltered again through 
40-μm mesh cell strainers, and diluted to a density of  20,000,000 
cells/ml. Fluorescence-activated cell sorting (FACS) was conducted 
as described previously (Veizis and Cotton, 2005) using a Beckman 
Coulter Epics Elite cell sorter. CT media contains equal parts of 
DMEM and Ham’s F-12 medium and is supplemented with 1.3 μg/
liter sodium selenite, 1.3 μg/liter 3,3′5-triiodo-l-tyronine, 5 mg/liter 
insulin, 5 mg/liter transferrin, 25 mg/liter prostaglandin E1, 2.5 mM 
glutamine, and 50 nM dexamethasone.
Transepithelial Electrical Measurements
Cells were seeded onto collagen-coated permeable supports 
(Millicell CM fi  lters, 12 mm; Millipore) at a density of 1.0 or 2.5 × 
105 cells/fi  lter for MDCK and primary renal cells, respectively, as 
described previously (Shen and Cotton, 2003; Veizis et al., 2004). 
MDCK cells were grown in IM for 2 d while primary renal cells 
were grown for 7–10 d at 37°C in CT media. Media was changed 
daily on fi  lters. Filters were mounted in an Ussing chamber 
equipped with gas inlets and separate reservoirs for the perfusion 
of the apical and basolateral compartments with solutions main-
tained at 37°C with a circulating water jacket. Both sides were 
bathed in equal volumes of CT media that was oxygenated with 
95% O2, 5% CO2 to maintain a pH of 7.4. Agar bridges were posi-
tioned 3 mm from the surface of the fi  lters and the transepithelial 
voltage potential (VT) measured. The current required to clamp the 
VT to 0 mV (ISC) was determined after compensation for solution 
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short-circuit current conditions except for short intervals when 
the current is clamped to a nonzero value (1–5 mV) for 5 s to 
allow for the calculation of the transepithelial resistance (RT).
Creation of MDCK Cell Lines
Mutagenesis was performed on rat βENaC within the PCR2.1 
cloning vector using the QuikChange Site-directed Mutagenesis 
Kit (Stratagene) according to the manufacturer’s instructions. In-
sertion of the FLAG tag into the extracellular loop between resi-
dues T137 and S138, a site that has been previously characterized 
as not affecting channel activity (Firsov et al., 1996), was accom-
plished with two rounds of mutagenesis using primers 5′-CCA 
CAG CAA CAC CAC CGA CTA CAA GGA CAG GAC CCT GAA 
CTT TAC CAT CTG G-3′ and 5′-CCA GAT GGT AAA GTT CAG 
GGT CCT GTC CTT GTA GTC GGT GGT GTT GCT GTG G-3′ 
for the fi  rst round and 5′-CCA CCG ACT ACA AGG ACG ACG 
ACG ACA AGA GGA CCC TGA ACT TTA CC-3′ and 5′- GGT AAA 
GTT CAG GGT CCT CTT GTC GTC GTC GTC CTT GTA GTC 
GGT GG-3′ for the second round. The G525C mutation was then 
made to the FLAG-tagged βENaC using primers 5′-CCT GGG 
GGG CCA GTT TTG CTT CTG GAT GGG GGG CTC GG-3′ and 
5′-CCG AGC CCC CCA TCC AGA AGC AAA ACT GGC CCC CCA 
GG-3′. The single point mutations were then made in the G525C 
and FLAG-tagged βENaC with the primer sets 5′-GCA AAG GCC 
TGC GCA GGA GGT GAC CAC AGG CAC CC-3′ and 5′-GGG TGC 
CTG TGG TCA CCT CCT GCG CAG GCC TTT GC-3′; 5′-GCC CAT 
CCC GGG GAC TCC ACC CAA GAA CTA TGA CTC CCT GAG G-3′ 
and 5′-CCT CAG GGA GTC ATA GTT CTT GGG TGG AGT CCC 
CGG GAT GGG C-3′; 5′-GCC CAT CCC GGG GGC CCC ACC 
CCC-3′ and 5′-GGG GGT GGG GCC CCC GGG ATG GGC-3′; and 
5′-CGT GTG GCT GCT CAA AAA CCT GGG GGG CC-3′ and 5′-GGC 
CCC CCA GGT TTT TGA GCA GCC ACA CG-3′ for R564stop, 
P616L, T613A, and S518K, respectively. All mutations were verifi  ed 
by sequencing.
A retroviral expression system was used in this study. βENaC 
was subcloned into the Phoenix retroviral vector, pBMN-I-GFP, a 
bicistronic vector that expresses GFP from an internal ribosomal 
entry site (IRES), allowing for positive selection by FACS. Direc-
tional subcloning was performed using the EcoRI and XhoI re-
striction sites. Proper orientation was verifi  ed by sequencing. The 
Phoenix amphotropic HEK293 packaging cell line was transfected 
with the retroviral plasmids using Fugene 6 (Roche) transfection 
reagent according to manufacturer’s instructions. Subconfl  uent 
plates of MDCK cells were transduced with the resulting retroviral 
supernatant. For creation of clonal cell lines, MDCK cells were 
grown for 2 wk and then subjected to FACS. The sorted cells were 
returned to GM and grown for an additional 2 wk and subjected to 
FACS again. All cells exhibiting fl  uorescence readings greater than 
Figure 1.  Effect of EGF on 
amiloride-sensitive ISC and 
ERK1/2 phosphorylation in 
primary renal collecting duct 
cells. (A) Confl  uent  mono-
layers of primary renal col-
lecting duct cells isolated 
from homozygous wild type 
(+/+) or Liddle’s (L/L) 
mice were mounted in Ussing 
chambers and bathed on 
both sides with CT media. At 
the indicated time either 
EGF (20 ng/ml) or vehicle 
was added to the basolateral 
compartment. After 30 min, 
amiloride (100 μM) was 
added to the apical compart-
ment. The vertical defl  ec-
tions are at 1-min intervals 
and represent the change in 
current when the voltage is 
clamped to a nonzero value 
to measure transepithelial re-
sistance. (B) Time course for 
EGF-induced inhibition of 
amiloride-sensitive Isc (INa). 
Mean ± SEM for INa taken at 
2-min intervals after addition 
of EGF (t = 0 min) to L/L 
(open circles; n = 8) or +/+ 
cells (closed circles; n = 9). 
(C) Summary of acute in-
hibition of INa 30 min after 
addition of EGF. n  = 8–9. 
*, P < 0.05. (D) Western blot 
analysis of total and phosphor-
ylated ERK1/2 in primary cultures of renal epithelial cells derived from either wild-type (+/+) or Liddle’s (L/L) mice. Confl  uent mono-
layers were treated with EGF (20 ng/ml, basolateral) or vehicle for 30 min with and without a 15-min pretreatment with an ERK kinase 
inhibitor (U0126, 10 μM, apical/basolateral). Equivalent amounts of cell lysate (20 and 10 μg of cell lysate protein for total ERK1/2 and 
phosphorylated ERK1/2, respectively) were loaded into each lane. The blot is representative of three independent experiments. 316 Acute Downregulation of ENaC by EGF
that exhibited by the parental cells were collected. At 5 wk the MDCK 
cells were subjected to single cell sorting into 96-well plates. Cells 
with fl  uorescence units at 103 or greater were designated high 
expression for use in this study. Cells with fl  uorescence in the 
range of 102–103 were designated medium expression and between 
101 and 102 low expression. Control cells exhibited fl  uorescence 
between 100 and 101 units. Mixed populations of G525C and 
S518K were obtained by sorting cells that had been transduced 
10 d earlier. Cells with fl  uorescence in the range of 102 and above 
were collected for study of mixed populations.
Western Blot and Immunoprecipitation
Cells were grown to confl  uence on 24-mm Transwell fi  lters (Co-
star) and MDCK cells were maintained for 48 h in serum-free IM 
before cell harvest. Monolayers were washed with ice-cold PBS 
and then 120 μl of RIPA lysis buffer was added to the fi  lter. RIPA 
lysis buffer consists of 50 mM Tris at pH 7.4, 0.10% IGEPAL, 2 mM 
EDTA, 1 mM EGTA, 150 mM NaCl, 0.10% SDS, 0.50% sodium de-
oxycholate, 50 μl/ml protease inhibitor cocktail in DMSO (Sigma-
Aldrich), 5 μl/ml phosphatase inhibitor cocktail 2 (Sigma-Aldrich), 
50 μM PMSF, 10 μM heat-activated sodium orthovanadate. Cells 
were then scraped off fi  lters and the lysates transferred to 1.5-ml 
tubes. The lysates were passed several times through a 25-G nee-
dle attached to a 1-ml syringe and then precleared by centrifuga-
tion at 14,000 rpm for 10 min at 4°C in a microcentrifuge. The 
lysates were then transferred to a fresh 1.5-ml tube, being careful 
to not disturb the pellet of cellular debris in the bottom of the 
tube, and stored on ice. The total protein concentration in each 
sample was determined using a BCA kit (Pierce Chemical Co.) 
according to manufacturer’s directions. Laemmli buffer contain-
ing β-mercaptoethanol was added to protein samples (10 μg for 
phospho-ERK and 5 μg for total ERK analysis), boiled for 4 min, 
and returned to ice for 1 min. Samples were run on 7.5% SDS-PAGE 
gels and transferred to nitrocellulose membranes. Membranes were 
probed with primary antibodies for p42/p44 (1:1,000, total ERK1/2; 
Cell Signaling Technologies) or phospho-p42/p44 (1:1,000, phos-
pho-ERK1/2; Cell Signaling Technologies) and anti-rabbit HRP 
secondary antibody (1:1,000; Cell Signaling Technologies). Other 
blots were probed for the FLAG-tagged βENaC using anti-FLAG 
M2 coupled to HRP (1:1,000; Sigma-Aldrich). Blots were devel-
oped by ECL chemiluminescence.
For immunoprecipitation, cell lysates were prepared in nonde-
naturing lysis buffer (ND) consisting of 50 mM Tris at pH 7.4, 1% 
Triton X-100, 5 mM EDTA, 300 mM NaCl, 0.02% sodium azide, 
50 μl/ml protease inhibitor cocktail in DMSO (Sigma-Aldrich), 
5 μl/ml phosphatase inhibitor cocktail 2 (Sigma-Aldrich), 50 μM 
PMSF, and 10 μM heat-activated sodium orthovanadate. Lysates 
were precleared with protein G and proteins were immuno-
precipitated with anti-FLAG M2 antibody (Sigma-Aldrich) and 
protein G beads (Sigma-Aldrich) overnight. Beads were then 
washed three times with IP wash buffer consisting of 50 mM Tris at 
pH 7.4, 0.10% Triton X-100, 5 mM EDTA, 300 mM NaCl, 0.02% so-
dium azide, 50 μl/ml protease inhibitor cocktail in DMSO (Sigma-
Aldrich), 5 μl/ml phosphatase inhibitor cocktail 2 (Sigma-Aldrich), 
50 μM PMSF, 10 μM heat-activated sodium orthovanadate. Pro-
teins were eluted in laemmli buffer with 5% β-mercaptoethanol at 
95°C for 5 min, separated by SDS-PAGE, and transferred to PVDF 
membranes (Millipore). Membranes were probed as described 
above for Western blots.
Surface Expression of βENaC
MDCK cells were grown to confl  uence on 24-mm Transwell fi  lters 
(Costar). EGF (20 ng/ml) was added to the basolateral compart-
ment for the indicated time. Filters were washed three times in 
ice-cold PBS and then biotinylated with sulfo-NHS-SS-biotin 
(Pierce Chemical Co.) according to a protocol modifi  ed from 
manufacturer’s instructions. In brief, a solution of 1.0 mg/ml of 
sulfo-NHS-SS biotin in sodium borate buffer (85 mM NaCl, 4 mM 
KCl, 15 mM Na2B4O7, pH 8.5) was made immediately before use 
and applied to the apical compartment. The fi  lters were then 
placed in a 4°C cold room on a rocker with gentle agitation for 
30 min. Filters were then washed once with 25 mM Tris PBS to 
quench unreacted biotin and then three times with ice cold PBS. 
Figure 2.  Effect of EGF on amiloride-sensitive ISC in confl  uent 
monolayers of parental MDCK cells. Cells were seeded onto 
collagen-coated fi  lters and grown in IM for 48 h. Filters were 
mounted in Ussing chambers and bathed on both sides with serum-
free GM. (A) Representative trace. The epithelial monolayer was 
maintained under short-circuit conditions, and at 1-min intervals 
the voltage was clamped to a small nonzero value to measure tran-
sepithelial resistance. At the indicated time, EGF (20 ng/ml) was 
added to the basolateral compartment and 30 min later, amiloride 
(100 μM) was added to the apical compartment. (B and C) Sum-
mary of the effects of EGF and U0126 on INa and transepithelial 
resistance. Confl   uent monolayers of induced parental MDCK 
cells were mounted in Ussing chambers and after the current sta-
bilized, vehicle (10 μl DMSO) or U0126 (10 μM, apical and baso-
lateral) was added. 30 min later, vehicle or EGF (20 ng/ml, 
basolateral) was added followed 30 min later by amiloride (100 
μM, apical). INa was calculated as the difference in ISC immedi-
ately before and after addition of amiloride. Transepithelial resis-
tance was measured near the beginning of the experiment after 
the current stabilized. n = 5 for each group. *, P < 0.05.  Falin and Cotton 317
Cells were then lysed in ND buffer and total protein concentra-
tion determined by a bicinchoninic acid protein assay. Lysates 
containing 400 μg total protein were combined with streptavi-
din agarose beads and tumbled overnight at 4°C. The beads were 
pelleted by centrifugation and the supernatant was removed and 
labeled “cytosol.” Sample buffer (2×) containing 5% β-mercapto-
ethanol was added to the beads, and beads were boiled for 3 min 
and then put on ice for 1 min. The entire volume was then ap-
plied to 5–20% gels, separated by SDS-PAGE, and transferred to 
PVDF membranes. At the same time the “cytosol” samples (20 μg 
total protein) were boiled with the proper volume of 5× sample 
buffer containing β-mercaptoethanol and applied to another 
5–20% gel and treated in the same way. The surface (eluted from 
beads) and cytosol βENaC was detected by an anti-FLAG M2 anti-
body and visualized by chemiluminescence. The blots were 
stripped and probed with anti-actin to confi  rm that cytosolic pro-
teins were not labeled with biotin.
Transgenic Mice
The Liddle’s syndrome mice, generated by insertion of a stop co-
don corresponding to the human R566 residue into the βENaC 
gene, were described previously (Pradervand et al., 1999). The 
Liddle’s mice were bred with the Hoxb7/EGFP transgenic line, 
which expresses enhanced green fl  uorescent protein specifi  cally 
in the collecting ducts. Pups were genotyped for the R566X-trun-
cation and the GFP transgene (GFP+/?) as previously described 
(Pradervand et al., 1999; Srinivas et al., 1999). F2 pups that were 
either homozygous mutant (L/L) or wild-type (+/+) for β-ENaC 
and carried the GFP transgene were selected for isolation, sort-
ing, and culture of collecting duct cells.
Statistical Analysis
All results are expressed as mean ± SEM. Statistical signifi  cance 
was evaluated by either paired or unpaired Student’s t test. P < 
0.05 was considered signifi  cant.
RESULTS
Deletion of the β-ENaC Subunit C Terminus Blocks 
EGF-induced Inhibition of Amiloride-sensitive 
Sodium Absorption
Previous studies have demonstrated EGF-induced inhibi-
tion of ENaC-mediated sodium absorption in murine renal 
collecting duct cells. The inhibitory response developed 
rapidly (5–20 min) and required activation of the 
ERK1/2 MAP kinase signaling cascade; however, the 
mechanism for this acute reduction in ENaC activity was 
not explored. A putative ERK1/2 phosphorylation site is 
located in the C terminus of β-ENaC (β−T613) and 
phosphorylation of the site is proposed to increase bind-
ing of a ubiquitin ligase Nedd4, channel ubiquintylation, 
and internalization. A mouse model of Liddle’s syn-
drome in which the C terminus of β-ENaC is truncated 
(R564stop), was used to determine if an intact β-ENaC 
is required for EGF-induced inhibition of sodium ab-
sorption. Amiloride-sensitive short-circuit current was 
measured in primary cultures of renal collecting duct 
epithelial cells derived from wild type (+/+) and ho-
mozygous mutant (L/L) mice. As expected, the cells 
isolated from mice homozygous for the Liddle’s muta-
tion (L/L) exhibited a higher amiloride-sensitive ISC 
(16.3 ± 1.5 μA/cm2; n = 8) than their wild-type (+/+) 
littermates (12.3 ± 2.1 μA/cm2; n = 9). In both cases, 
>90% of the ISC was inhibited by amiloride. Addition of 
EGF to the basolateral bathing solution elicited the char-
acteristic decline in ISC in monolayers of wild-type cells 
(+/+); however, the response of monolayers of mutant 
cells (L/L) was substantially reduced (Fig. 1 A). Sum-
mary data for the time course of EGF-induced inhibition 
of amiloride-sensitive short-circuit current (INa) in +/+ 
and L/L monolayers is shown in Fig. 1 B. The EGF-in-
duced decrease in amiloride-sensitive ISC for monolayers 
of L/L cells is signifi  cantly attenuated compared with 
that of the +/+ cells ( 75%; Fig. 1 C). The EGF-in-
duced increase in ERK1/2 phosphorylation is similar in 
collecting duct cell monolayers from +/+ and L/L 
mice (Fig. 1 D). Deletion of the intracellular β-ENaC C 
terminus eliminates several consensus phosphorylation 
sites as well as two internalization motifs (PY and YXXφ). 
To explore the importance of the PY motif and putative 
ERK phosphorylation site in the acute downregulation 
of ENaC by EGF-induced ERK1/2 activation, a stable 
mammalian expression system was developed.
Figure 3. Dose–response  relation-
ships for amiloride and benzamil 
inhibition of INa in engineered 
MDCK cell lines transduced with 
the FLAG-tagged β-ENaC. Vali-
dation of the G525C mutation. 
(A) Monolayers of MDCK cells 
stably expressing FLAG-tagged 
β-ENaC (circles; FLAG) or FLAG-
tagged/G525C β-ENaC (tri angles; 
G525C) were grown to confl  uence 
and mounted in Ussing chambers. 
Increasing concentrations of 
benzamil (blue) and amiloride 
(red) were added to the apical 
compartment and the relative INa determined as the ratio of the INa at the indicated concentration and that at the start of the experiment. 
(B) The fraction of total INa that was insensitive 1 μM benzamil (i.e., channels with a G525C β-ENaC) in MDCK cell lines stably expressing 
FLAG-tagged β-ENaC (FLAG) or FLAG-tagged/G525C β-ENaC (G525C).318 Acute Downregulation of ENaC by EGF
Generation and Characterization of MDCK Cell Lines 
with Stable Expression of Mutant β-ENaC
Type I MDCK cells form high-resistance polarized epi-
thelial monolayers. A MDCK line with inducible expres-
sion of all three subunits of rat ENaC from a tricistronic 
vector was chosen as the parental cell line for these 
studies (Stutts et al., 1995). To confi  rm that EGF-induced 
inhibition of sodium transport was retained in this cell 
line, ENaC expression was induced in confl  uent mono-
layers of parental MDCK cells for 48 h and the effect of 
EGF on amiloride-sensitive short-circuit current was ac-
cessed. A representative trace shows that MDCK mono-
layers generate a large Isc and addition of EGF to the 
basolateral bathing solution reduces Isc by  30% (Fig. 
2 A). Subsequent addition of amiloride to the apical bath-
ing solution reduces the Isc to near zero. If the mono-
layer is fi  rst treated with amiloride, Isc is reduced to near 
zero, and subsequent exposure to EGF does not further 
reduce Isc (unpublished data). Additional experiments 
were done to confi  rm that the EGF-induced inhibition 
of sodium absorption required ERK1/2 phosphoryl-
ation. Pretreatment of MDCK monolayers with an ERK 
kinase inhibitor (U0126) prevents ERK1/2 phosphor-
ylation and EGF-induced inhibition of amiloride-sensi-
tive Isc as was observed in previous studies of mouse 
renal collecting duct cell monolayers (Veizis et al., 2004; 
Falin et al., 2005; Veizis and Cotton, 2005). The effects 
of EGF and U0126 on INa and transepithelial resistance 
are summarized in Fig. 2 (B and C).
A retroviral expression system was used to introduce 
engineered forms of β-ENaC into parental MDCK cells. 
Since the parental MDCK cell line expresses wild-type 
β-subunit, it was necessary to use β-ENaC constructs that 
contain an inserted extracellular FLAG epitope and a 
G525C mutation. The G525C mutation shifts the Ki for 
Figure 4.  Creation of the MDCK cell lines stably expressing 
engineered β-ENaC. (A) Diagrammatic representation of the modifi  -
cations/mutations introduced into β-ENaC and stably expressed 
in MDCK cells. The name of each cell line is listed above and the 
modifi  cations/mutations present within the channel are below 
the drawing. (B) Parental and clonal cell lines were harvested and 
analyzed for expression of the FLAG-tagged β-ENaC subunit. 
Anti-FLAG M2 antibody was used to immunoprecipitate FLAG-
tagged β-ENaC from cell lysates. Bound proteins were eluted, sep-
arated by SDS-PAGE, and probed with an M2 anti-FLAG antibody. 
(C) Summary of INa in confl  uent monolayers of clonal MDCK cell 
lines stably expressing modifi  ed/mutated βENaC subunits (n = 5). 
INa was calculated as the fraction of ISC that was insensitive to 1 μM 
benzamil, but blocked by 10 mM amiloride. (D) Summary of tran-
sepithelial resistance in MDCK cell lines (n = 5).
Figure 5.  Effect of EGF on short-circuit current in parental and 
modifi  ed MDCK cell lines. Parental MDCK cells were transduced 
with empty retroviral vector, FLAG-tagged wild-type β-ENaC, or 
FLAG-tagged/G525C β-ENaC (all transduced lines express GFP 
under the control of IRES). (A–D) Cells were grown to confl  u-
ence on fi  lters and mounted in Ussing chambers. After currents 
stabilized, EGF (20 ng/ml, basolateral) was added followed 30 
min later by amiloride (10 mM, apical for G525C; 100 μM, apical 
for others). (E) Summary of EGF-induced inhibition of INa (n = 5 
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amiloride and benzamil block to higher concentrations 
and allows a functional distinction between channels 
that contain a wild-type verses a modifi  ed  β-subunit 
(Schild et al., 1997). Parental MDCK cells were trans-
duced with β-subunit containing both the FLAG tag and 
the G525C mutation or the FLAG tag alone. The benza-
mil and amiloride dose–response curves for inhibition 
of Isc in cells that express FLAG-tagged β-ENaC subunits 
yield Kis of 18 and 84 nM; whereas the Kis for benzamil 
and amiloride were shifted to 2.9 and 36 μM in cells that 
express the G525C mutation (Fig. 3 A). Application of 
1 μM benzamil blocks essentially all of the amiloride-
sensitive Isc due to ENaC channels that contain a β-ENaC 
subunit that lacks the G525C mutation (i.e., endoge-
nous wild-type channels), while leaving most of the cur-
rent through channels containing the β-ENaC G525C 
mutation (Fig. 3). Channels that contain a β-ENaC sub-
unit with the G525C mutation are blocked by 10 mM 
amiloride. Thus, the modifi  cations to β-ENaC confer 
unique functional and biochemical attributes to chan-
nels that contain the engineered subunit.
Three types of mutations were introduced into the 
β-ENaC subunit in order to evaluate the importance of 
specifi  c sites in ERK-dependent inhibition of sodium 
transport. A truncation mutation (R564st) to mimic the 
Liddle’s mouse model, a PY motif mutation (P616L), 
and a mutation in the putative ERK phosphorylation site 
located adjacent to the PY motif (T613A). MDCK cells 
were transduced with the β-ENaC subunit containing 
the FLAG tag, the G525C mutation, and one of the 
three additional mutations (Fig. 4 A). Stable MDCK cell 
lines were created by FACS-positive selection, and ex-
pression of the mutant β-ENaC subunit was confi  rmed 
(Fig. 4 B). MDCK cells from each of the cell lines were 
seeded onto permeable supports, grown to confl  uence, 
and wild-type ENaC expression was induced for 48 h be-
fore electrophysiological characterization. The amilo-
ride-sensitive Isc and transepithelial resistance for each 
cell line are summarized in Fig. 4 (C and D). The values 
for amiloride-sensitive ISC and transepithelial resistance 
were not signifi  cantly different among the cell lines that 
carried the mutant β-ENaC subunit or compared with 
the parental line (Fig. 4, C and D).
EGF-induced Inhibition of Sodium Transport Requires 
ERK1/2 Phosphorylation and an Intact 𝗃-ENaC Subunit
The effect of EGF on sodium absorption was evaluated 
in confl  uent monolayers maintained under short-circuit 
conditions in Ussing chambers. In the case of the G525C 
mutation cell line, it was necessary to add 1 μM benza-
mil to the apical bathing solution to block endogenous 
channels that contain wild type β-ENaC subunit. Repre-
sentative traces are illustrated in Fig. 5 (A–D) and the 
summary data in Fig. 5 E. In each cell line tested, EGF 
treatment elicited the characteristic 30–40% reduction 
in amiloride-sensitive Isc.
Figure 6.  Effect of EGF on short-circuit current in 
MDCK cell lines stably expressing mutant β-ENaC sub-
units. (A–D) Representative traces of short-circuit cur-
rent in confl  uent monolayers of G525C, R564st, P616L, 
and T613A MDCK cell lines. At the indicated times ben-
zamil (1 μM, apical), EGF (20 ng./ml, basolateral), and 
amiloride (10 mM, apical) were added. (E) The initial 
INa is the benzamil-insensitive, amiloride-sensitive, short-
circuit current measured in three independent clonal 
cell lines for each mutation (n  = 5 fi   lters for each 
clone). (F) Summary of EGF-induced inhibition of INa 
in three independent clonal cell lines for each mutation 
(n = 5 fi  lters for each clone). *, P < 0.05.320 Acute Downregulation of ENaC by EGF
The effect of EGF on ENaC-mediated sodium ab-
sorption in MDCK cell lines that express mutant β-ENaC 
was determined. Endogenous channels that contain 
wild-type β-ENaC were blocked by addition of 1 μM 
benzamil to the apical bathing solution followed by 
addition of EGF (20 ng/ml) to the basolateral bathing 
solution. Representative traces from each of the four 
cell lines are shown in Fig. 6 (A–D). In each case, ben-
zamil reduced Isc by  10%, indicating that only a small 
fraction of the current was due to channels that con-
tained a wild-type β-ENaC subunit with the majority of 
the current carried by channels that contained a mu-
tant β-ENaC subunit. EGF treatment resulted in  30% 
reduction in Isc in the G525C cell line with only small 
inhibitory responses in the R564st, P616L, and T613A 
cell lines. Since the site of retroviral integration into 
the MDCK cell genome is undefi  ned, it was necessary 
to evaluate multiple clonal cell lines to ensure that lo-
cation of integration of the vector was not the cause of 
differences observed in the cell lines. Three clonal 
cell lines for each mutation were generated and evalu-
ated and the results are summarized in Fig. 6 (E and 
F). The amiloride-sensitive short circuit currents and 
the effects of EGF on Isc were similar within the clonal 
lines for each mutation. Amiloride-sensitive ISC was 
the same for the G525C and the R564st mutation, 
while it was slightly increased in P616L and T613A mu-
tations (Fig. 6 E). Monolayers of G525C clonal cell 
lines exhibited 28–35% acute inhibition in response 
to EGF while the R564st and P616L clonal cell lines 
were inhibited by 6–9% and the T613A clonal cell 
lines 8–12% (Fig. 6 F).
Previous studies have shown that EGF-induced inhi-
bition of sodium transport in renal epithelial cells is 
ERK1/2 dependent. EGF-induced ERK1/2 phosphory-
lation was evaluated in confl  uent monolayers of G525C, 
R564st, P616L, and T613A cell lines. Addition of EGF to 
the basolateral bathing solution for 15 min increased 
ERK1/2 phosphorylation (pERK1/2) three to fourfold 
with no effect on total ERK1/2 (tERK1/2) (Fig. 7, A 
and B). Exposure to an ERK kinase inhibitor (U0126) 
reduced basal pERK1/2 and completely blocked EGF-
induced ERK1/2 phosphorylation. In a parallel series 
of experiments, the effect of the ERK kinase inhibitor 
on EGF-induced inhibition of Isc was evaluated. As shown 
in Fig. 7 C, pretreatment with U0126 completely pre-
vented the 35% decrease in Isc in G525C monolayers in 
response to EGF. Interestingly, the small inhibitory re-
sponse to EGF observed in P616L and T613A β-ENaC 
cell lines was also blocked by U0126. Together these re-
sults suggest that both the PY motif and the putative ERK 
phosphorylation site in the β-ENaC subunit of the chan-
nel are required for full ERK1/2-mediated acute inhibi-
tion of ENaC activity and sodium absorption.
EGF-induced Inhibition of Sodium Absorption 
Is due to Sequential Effects on Channel Activity 
and Surface Expression
Liddle’s syndrome mutations have been associated with 
reduced channel endocytosis and enhanced surface 
expression presumably due to elimination or disruption 
of the PY motif in the C terminus of β- and γ-ENaC 
subunits. Acute inhibition of sodium absorption is con-
sistent with an ERK1/2-mediated decrease in ENaC 
Figure 7.  EGF-induced ERK1/2 phosphorylation and 
p-ERK1/2–dependent inhibition of INa in MDCK cell lines. 
G525C, R564st, P616, and T613A MDCK cell lines were 
grown to confl  uence on fi  lters and bathed in IM for 48 h. 
(A) Individual monolayers were treated with vehicle (lane C; 
DMSO, 10 μl, both sides, 45 min), EGF (lane E; EGF, 
20 ng/ml, basolateral, 15 min), ERK kinase inhibitor (U; 
U0126, 10 μM, both side, 45 min), or ERK kinase inhibitor 
plus EGF (U + E; U0126, 10 μM, both side, 30 then EGF, 
20 ng/ml, basolateral, 15 min). Cells were then lysed, sepa-
rated by SDS-PAGE, and probed for phosphorylated 
ERK1/2 and total ERK1/2. The blots are representative of 
three independent experiments. Densitometry was per-
formed on each blot and the ratio of pERK1/2 to total 
ERK1/2 was determined for each cell line under each con-
dition and the data are summarized in B. (C) Confl  uent 
monolayers of G525C, R564st, P616L, and T613A MDCK 
cell lines were exposed to EGF (20 ng/ml, 30 min, basolat-
eral) with or without pretreatment with an ERK kinase in-
hibitor (U0126; 10 μM, 15 min, bilateral). The inhibition 
of INa was calculated as previously described. n = 5. P < 0.05. 
*, signifi  cantly different compared with G525C control; 
**, signifi  cantly different compared with monolayers not 
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surface expression since EGF-induced inhibition is al-
most completely prevented by the R564st and P616L 
mutations. However, the inhibitory response could be 
due to a decrease in channel open probability and/or a 
reduction in the number of active channels at the apical 
surface (decreased delivery/increased retrieval). The 
surface expression of ENaC was evaluated by biotinyla-
tion of apical membrane proteins followed by immuno-
precipitation and immunoblot. Confl  uent monolayers 
of G525C MDCK cells were treated with EGF for 0, 30, 
60, 90, and 120 min and then analyzed for total and sur-
face expression of ENaC. A representative immunoblot 
of surface and cytosolic ENaC is shown in Fig. 8 A and 
the results of all experiments are summarized in Fig. 8 B. 
Surface expression of ENaC was not decreased 30 min 
after EGF treatment, a time when the acute inhibitory 
response is fully developed. However, there was a signifi  -
cant reduction in surface expression of ENaC at later 
time points (60, 90, and 120 min). The temporal disso-
ciation between EGF-induced inhibition of Isc ( <30 
min) and decline in surface expression (>30 min) sug-
gests that the initial response may be a decrease in 
channel open probability rather than retrieval from the 
apical membrane. To investigate this possibility, the 
βS518K mutation, which when expressed in oocytes in-
creases the open probability of ENaC from  0.5 to 
nearly twice that, was used ( Condliffe et al., 2004). In 
our study the INa exhibited by the S518K mutant was not 
higher than G525C MDCK cells, as shown in Fig. 9 A. 
However, the percent inhibition by EGF exhibited by 
the S518K mutant was signifi  cantly greater than in G525 
cells (Fig. 9 B).
A potential complication of this analysis is that under 
certain conditions large numbers of ENaC channels are 
present at the plasma membrane in an inactive or silent 
state, presumably because they were not proteolytically 
cleaved and activated during channel assembly and 
maturation. In this case biochemical assays of channel 
number and functional assays of channel activity may 
not correlate. Silent or low activity channels can be acti-
vated by brief exposure to extracellular trypsin. To de-
termine if there was a signifi  cant population of silent, 
uncleaved channels that could distort the biochemical 
analysis of surface expression, the effect of trypsin on 
amiloride-sensitive Isc was evaluated in MDCK cell mono-
layers. Immediately after addition of trypsin (3 μg/ml) 
to the apical surface of confl  uent MDCK cell monolay-
ers there is a transient spike in Isc followed by a small in-
crease in Isc compared with the initial value (Fig. 10 A). 
The transient increase in Isc is not due to activation of 
silent ENaC channels since addition of amiloride (100 
μM, apical) to block ENaC before trypsin did not alter 
the transient current, but did prevent the small steady-
state increase in Isc (Fig. 10 B). The small increase in 
current was also observed in MDCK monolayers treated 
with EGF before exposure to trypsin (Fig. 10 C). There 
also was no difference in the small trypsin-induced in-
crease in current between G525C, P616L, and T613A 
MDCK cell monolayers (Fig. 10 D). The data suggest 
that under these experimental conditions, relatively few 
silent, trypsin-activatable sodium channels are present 
in the apical plasma membrane, and biochemical esti-
mates of surface expression are valid.
Since there is no change in surface expression of 
ENaC for at least 30 min after exposure to EGF, it is pos-
sible that ERK1/2-dependent inhibition of Isc is due to 
a reduction in channel open probability and should be 
reversible. Previous studies in collecting duct cell lines 
demonstrated that EGF-induced ERK1/2 phosphoryla-
tion and inhibition of amiloride-sensitive Isc were read-
ily reversed by treatment with an ERK kinase inhibitor 
(U0126) (Falin et al., 2005). To determine if there is a 
window of time during which the inhibitory response is 
reversible, the ERK kinase inhibitor was added 15, 30, 
45, or 60 min after EGF treatment of MDCK cell mono-
layers. Summary traces are shown in Fig. 11 (A–D). The 
EGF-induced inhibition of Isc is completely reversible at 
15 and 30 min, partially reversible at 45 min, and almost 
completely irreversible at 60 min (Fig. 11, E and F).
Figure 8.  Time course for EGF-induced decrease in β-ENaC 
surface expression. (A) Surface expression of β-ENaC was deter-
mined by biotinylation and recovery of labeled apical membrane 
proteins by incubation with streptavidin beads. Biotinylated api-
cal membrane and cytosolic protein samples were loaded on gels, 
separated by SDS-PAGE, transferred to nitrocellulose membranes, 
and probed with the M2 anti-FLAG antibody coupled to HRP to 
detect β-ENaC. The membranes were stripped and probed for 
actin. (B) Densitometry was performed and the ratio of surface to 
cytosol β-ENaC was determined for each sample and normalized 
to the ratio obtained at t = 0. n = 4. *, signifi  cantly different com-
pared with ratio at t = 0. P < 0.05.322 Acute Downregulation of ENaC by EGF
ERK1/2-dependent Inhibition of Sodium Transport 
Is Not due to a Reduction in Channel Delivery
Under steady-state conditions where Isc is constant, the 
rates of delivery and retrieval of ENaC from the apical 
plasma membrane should be equivalent. In principle, 
EGF-induced inhibition of Isc could result from a reduc-
tion in the rate of channel delivery to the membrane. 
Brefeldin A (BFA), which blocks transport of protein 
from the ER to the Golgi network, was used to inhibit 
the traffi  cking of new ENaC channels to the plasma 
membrane. As illustrated in Fig. 12 (A and B) and sum-
marized in Table I, in the presence of BFA, the rates of 
decline of amiloride-sensitive Isc were not signifi  cantly 
different in G525C and T613A MDCK monolayers. Fur-
thermore, the functional half-life following BFA treat-
ment is similar to the half-life for surface expression of 
ENaC recently reported in another MDCK cell line ex-
pressing wild-type and Liddle’s mutant ENaC (Chen 
et al., 2007). However, in monolayers treated with U0126 
to reduce ERK1/2 phosphorylation, the rate of decline 
in Isc was signifi  cantly reduced in G525C monolayers 
but was unaffected in T613A monolayers. Furthermore, 
in monolayers treated with EGF, the rate of decline in Isc 
in G525C cells was signifi  cantly greater than T613A cells. 
Thus, the p-ERK1/2–dependent decrease in Isc was ap-
proximately two times greater in G525C monolayers 
compared with monolayers of cells that carried a muta-
tion in the putative ERK1/2 phosphorylation site 
(T613A) in the C terminus of β-ENaC (Table I).
DISCUSSION
We demonstrated previously that activation of the RAF/
MEK/ERK signaling cascade by exposure to EGF results 
in biphasic inhibition of amiloride-sensitive sodium ab-
sorption in renal collecting duct cells. Prolonged activa-
tion causes a 50–60% reduction in sodium current and 
a 70–85% decrease in expression of ENaC subunit 
mRNAs (Shen and Cotton, 2003); whereas the early in-
hibitory phase develops within minutes and cannot be 
attributed to changes in ENaC expression (Falin et al., 
2005). The acute, EGF-induced inhibition of epithelial 
sodium channel activity is thought to involve changes in 
channel gating and/or channel retrieval from the plasma 
membrane. The results of the present study demon-
strate that there are critical sites in the intracellular C 
Figure 9.  EGF-induced inhibition of INa in 
βG525C and βG525C/S518K mutant cell lines. 
Cells were grown to confl  uence on fi  lters and 
mounted in Ussing chambers. After currents sta-
bilized, benzamil (1 μM, apical) was added fol-
lowed 5 min later by EGF (20 ng/ml, basolateral) 
addition, followed 30 min later by amiloride (10 
mM, apical). (A) Initial INa was calculated as the 
ISC immediately before addition of EGF minus 
the Isc after addition of amiloride. (B) Summary 
of EGF-induced inhibition of INa (n = 6 for each 
cell line). *, P < 0.05.
Figure 10.  Effect of EGF and β-ENaC mutations on 
activation of amiloride-sensitive short-circuit current 
by trypsin. (A) Representative trace of a parental 
MDCK cell line monolayer mounted in an Ussing 
chamber and exposed to apical trypsin (3 μg/ml) 
followed by amiloride (10 μM). (B) Representative 
trace of a parental MDCK cell line monolayer treated 
with apical amiloride (10 μM) followed by trypsin 
(3  μg/ml). (C) Confl   uent monolayers of G525C 
MDCK cells were mounted in Ussing chambers and 
treated with benzamil (1 μM, apical) to block en-
dogenous sodium channels. 5 min later, either vehi-
cle or EGF (20 ng/ml, basolateral) was added. At 35 
min, trypsin (3 μg/ml, apical) was added, and at 50 
min amiloride (10 mM, apical) was added. INa-trp/INa 
was calculated from the INa 15 min after trypsin addi-
tion divided by the INa immediately before trypsin 
addition. (D) G525C, P616L, and T613A MDCK cell 
line monolayers were mounted in Ussing chambers. 
Benzamil (1 μM, apical) was added at the start of the 
experiment, at 5 min trypsin (3 μg/ml, apical) was 
added followed by amiloride (10 mM, apical) at 20 min. 
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terminus of β-ENaC that are required for ERK1/2-
dependent inhibition of sodium current and that the 
inhibitory response is due to sequential effects on chan-
nel activity and surface expression.
Truncation of β-ENaC C Terminus
Pradervand et al. (1999) generated a mouse model for 
Liddle’s syndrome by insertion of a stop codon in the 
mouse β-ENaC gene locus (R564st). The heterozygous and 
homo  zygous mutant mice failed to exhibit the Liddle’s 
phenotype (i.e., hypokalemia, metabolic alkalosis, and 
hypertension) until placed on a high salt diet, most 
likely due to poor expression of the mutant β-ENaC 
subunit. In vivo manipulations such as aldosterone in-
fusion, dietary sodium restriction, and a high- K diet 
were found to cause exaggerated increases in amilo-
ride-sensitive sodium current in cortical collecting duct 
cells from Liddle’s mice, primarily attributable to an 
increase in channel density (Dahlmann et al., 2003). In 
vitro studies of murine collecting duct cell lines trans-
fected with the R564st mutation demonstrated that 
induction of sodium absorption by aldosterone was simi-
lar between wild-type and mutant channels; however, 
downregulation of sodium current following aldoste-
rone withdrawal was signifi  cantly slowed in cells with 
mutant ENaC (Auberson et al., 2003). Interestingly, 
transition from low-sodium to high-sodium diet elicited 
a rapid redistribution of ENaC from the apical mem-
brane to the cytoplasm in connecting tubules from 
wild-type mice but not Liddle’s mice (Pradervand et al., 
2003). EGF-induced inhibition of amiloride-sensitive 
Isc in primary culture collecting duct cells isolated from 
Liddle’s mice and MDCK cells that express the R564st 
β-ENaC mutation was substantially reduced (Figs. 1 
and 6). Although the acute inhibition of Isc by EGF was 
greatly reduced, it was not completely abolished. This 
fi  nding suggests that the C terminus of the γ-subunit is 
suffi  cient for partial EGF-induced inhibition, while the 
C termini of both the β and γ subunits are required for 
the full inhibitory effect to occur. Michlig et al. (2005) 
reported that truncation of all three ENaC subunits 
prevented progesterone-induced inhibition of sodium 
current in an oocyte expression system. It is also possi-
ble however that there are parallel actions of EGF on 
ENaC activity, one that depends on the intact C termi-
nus of the β-subunit and another that does not. For ex-
ample, heterologous expression of ENaC and the EGF 
receptor in CHO cells reconstituted a response in which 
Figure 11.  Reversibility of EGF-induced inhibition of amiloride-
sensitive short-circuit current by an ERK kinase inhibitor. (A–D) 
Confl  uent monolayers of G525C MDCK cells were mounted in 
Ussing chambers and benzamil (1 μM) was added to the apical 
compartment. After the currents stabilized, EGF or vehicle (media) 
was added to the basolateral compartment. At various times there-
after (15, 30, 45, and 60 min), U0126 (10 μM) was added to the 
apical and basolateral compartments. Amiloride (10 mM) was 
added to the apical compartment at the end of experiment. The 
ISC
t/ISC
t=0 was calculated as the ratio of the ISC at each time point 
divided by the ISC at t = 0. Values represent mean ± SEM of the Isc 
recorded at 2-min intervals. (E) Summary of the time course for 
EGF-induced inhibition of amiloride-sensitive short-circuit cur-
rent. EGF-induced inhibition in INa was calculated immediately 
before the addition of U0126 as difference between the ISC
t /ISC
t=0 
for cells treated with EGF and those treated with vehicle. n = 5, 
P < 0.05. *, signifi  cantly different from zero. (F) The relative re-
versibility of EGF-induced inhibition of Isc was determined 30 min 
after the addition of U0126. It was calculated as the ISC
t=end/ISC
t=0 
for EGF-treated cells divided by the ISC
t=end/ISC
t=0 for vehicle-
treated cells. n = 5, P < 0.05. *, signifi  cantly different from 1.
TABLE I
Rates of Change in ISC,amil in BFA-treated Monolayers
G525C T613A
%/min %/min
Vehicle −1.06 ± 0.22 −0.78 ± 0.10 
EGF −3.73 ± 0.25 −2.61 ± 0.26a
U0126 +0.12 ± 0.46 −0.80 ± 0.04a
U0126-EGF 3.85 ± 0.52 1.81 ± 0.26a
The rate of decline in ISC in BFA-treated monolayers was determined. 
The monolayers were treated as described in Fig. 12. The ERK-dependent 
decline in ISC was calculated as the difference between the rates for EGF 
and U0126 treated monolayers. n = 5 for each group.
aSignifi  cant difference between response in G525C cells, P < 0.05.324 Acute Downregulation of ENaC by EGF
EGF-induced inhibition of ENaC activity did not require 
ERK activation (Tong and Stockand, 2005).
Point Mutation of the PY Motif and the Putative ERK 
Phosphorylation Site in β-ENaC
Deletion of the intracellular β-ENaC C terminus elimi-
nates several consensus phosphorylation sites as well as 
two internalization motifs (PY and YXXφ) important for 
Nedd4- and dynamin/clathrin-dependent endocytosis. 
To test the importance of individual sites, point muta-
tions were evaluated. Disruption of the PY motif by 
mutation of β-ENaC P616L (a human Liddle’s disease 
causing mutation) was as effective as the R564st β-ENaC 
truncation mutation for preventing the EGF-induced in-
hibition of sodium absorption in MDCK cell monolayers 
(Fig. 6). A similar result was obtained from studies of 
oocytes in which point mutations in the PY motif of either 
β- or γ-ENaC (Y618A or Y628A, respectively) were found 
to completely prevent progesterone-induced inhibition 
of sodium current (Michlig et al., 2005). Whereas, muta-
tion of the putative ERK phosphorylation sites in either 
β-ENaC (T613A) or γ-ENaC (T623A) reduced the pro-
gesterone-induced inhibition of sodium current by only 
20–25% (Michlig et al., 2005). In contrast, mutation of 
the putative ERK phosphorylation site in β-ENaC stably 
expressed in MDCK cells (T613A) was as effective as the 
R564st β-ENaC truncation (Fig. 6). Furthermore, the 
small inhibitory effect of EGF on sodium transport in 
MDCK cells expressing the R564st, P616L, and T613A 
mutations was completely abolished by an ERK kinase 
inhibitor (Fig. 7), consistent with a role for the corre-
sponding PY motif and putative ERK phosphorylation 
site in the C terminus of the γ-ENaC subunit.
Mechanism of ERK-dependent Inhibition 
of Sodium Absorption
We have shown previously that the acute, EGF-induced 
inhibition of amiloride-sensitive Isc in renal epithelial 
cells is localized to the apical membrane, presumably 
due to changes in ENaC expression or gating (Falin 
et al., 2005). EGF receptor-mediated activation of intra-
cellular signaling cascades could lead to changes in 
membrane potential and/or intracellular ion composi-
tion suffi  cient to alter the electrochemical potential dif-
ference for sodium across the apical membrane, but it is 
diffi  cult to reconcile such a mechanism with the observa-
tion that β-ENaC mutations abrogate the ERK-dependent 
inhibition of sodium absorption. The acute inhibitory ef-
fect of EGF on ENaC-mediated sodium absorption could 
be due to (a) reduced channel delivery to the apical mem-
brane, (b) relative increase in delivery of uncleaved, inac-
tive channels to the apical membrane, (c) enhanced 
retrieval of active channels from the membrane, or (d) de-
creased channel open probability.
Channel Delivery
The effects of decreased (U0126) and increased (EGF) 
ERK1/2 phosphorylation on Isc in BFA-treated mono-
layers are inconsistent with a major effect of p-ERK1/2 
on ENaC delivery (Fig. 12 and Table I). If EGF-induced 
inhibition of sodium current was due to reduced deliv-
ery, then EGF should be ineffective in BFA-treated 
G525C monolayers. Interestingly, reduction in basal 
p-ERK1/2 with the ERK kinase inhibitor slowed the de-
cline in Isc in G525C monolayers but had no effect in 
cells in which the putative ERK phosphorylation site in 
β-ENaC was mutated (T613A). Similar experiments 
conducted in the absence of BFA revealed that U0126 
increased Isc in G525C monolayers (17.6 ± 4.8%; n = 5) 
but had no effect in T613A monolayers (−0.3 ± 0.6%; 
n = 5), consistent with tonic ERK-mediated regulation 
of ENaC and sodium absorption.
Channel Cleavage
Recent studies have pointed to the importance of pro-
teolytic cleavage of the α and γ subunits in the activa-
tion of ENaC (Hughey et al., 2004; Kleyman et al., 2006; 
Sheng et al., 2006). Intracellular, membrane anchored, 
Figure 12.  Effect of ERK1/2 phosphor-
ylation on INa following treatment with 
brefeldin A. (A and B) G525C and T613A 
MDCK cells grown to confl  uence were 
mounted in Ussing chambers, treated 
with benzamil (1 μM) to block channels 
with endogenous β-ENaC subunits and 
then exposed to vehicle or brefeldin A 
(20 μM; 30 min, bilateral) to inhibit 
delivery of new channels to the plasma 
membrane. At t = −5min, monolayers 
were treated with EGF (20 ng/ml, baso-
lateral) or U0126 (10 μM, bilateral), and 
30 min later amiloride (10 mM, apical) 
was applied. The relative INa was calcu-
lated at 1-min intervals as the INa at 
each time point relative to the INa at t = 0. 
n = 5 for each group.  Falin and Cotton 325
and soluble proteases have been implicated in ENaC 
activation (Vuagniaux et al., 2000; Kleyman et al., 2006; 
Bruns et al., 2007). Excessive sodium absorption seen 
with Liddle’s mutations was found to be due not only to 
an increase in the number of channels at the plasma 
membrane (Schild et al., 1995; Snyder et al., 1995), but 
also in an increase in single channel activity (Firsov 
et al., 1996). Recently, it was reported that Liddle’s muta-
tions (R566X β-ENaC and K576X γ-ENaC) increase the 
fraction of cleaved, active channels at the plasma mem-
brane of transiently transfected Fisher rat thyroid and 
HEK 293 cells by 2–50-fold (Knight et al., 2006). Deliv-
ery of a greater proportion of uncleaved, inactive chan-
nels or a reduced rate of activation of channels at the 
apical membrane in response to EGF could account for 
the ERK-dependent decrease in amiloride-sensitive Isc. 
The results of the BFA (Fig. 12 and Table I) and the 
exogenous trypsin (Fig. 10) experiments suggest that 
alterations in channel cleavage cannot explain the 
EGF-induced inhibition of sodium absorption. Further-
more, we found that exogenous trypsin increased amil-
oride-sensitive Isc by only a small amount ( 15%) in 
MDCK cell monolayers expressing wild-type ENaC, a 
result incompatible with the existence of a large pool of 
silent, inactive sodium channels in the apical membrane 
of these cells.
Channel Retrieval
Liddle’s syndrome is caused by mutations in ENaC that 
disrupt or eliminate the PY motifs found in the intra-
cellular C termini of the β and γ subunits, thereby inter-
fering with Nedd4 binding and promoting channel 
retention in the plasma membrane (Schild et al., 1996; 
Staub et al., 1996). Garty and coworkers reported ERK-
dependent phosphorylation of amino acids near PY mo-
tifs in β- and γ-ENaC subunit, namely βT613 and γT623 
and enhanced binding to Nedd4 (Shi et al., 2002a). We 
showed that EGF-induced inhibition of sodium absorp-
tion is signifi  cantly attenuated by deletion or mutation 
of the PY motif and mutation of the putative ERK phos-
phorylation site (Figs. 1 and 6). These results point to 
enhanced channel retrieval as the mechanism for ERK-
mediated inhibition of ENaC activity. A relatively small 
fraction of ENaC is present at the plasma membrane 
so it was necessary to evaluate changes in surface ex-
pression by apical membrane biotinylation followed 
by immunoprecipitation of FLAG-tagged β-ENaC. Un-
expectedly, we found that surface expression of ENaC 
was not decreased 30 min after EGF treatment, a time at 
which EGF-induced inhibition of Isc was fully developed 
(Figs. 8 and 2). We cannot rule out the possibility that 
the individual ENaC subunits are differentially retrieved 
(Mohan et al., 2004). A large pool of inactive channels 
in the plasma membrane could also mask selective re-
trieval of a small subpopulation of functional channels. 
As described in the preceding section, it is unlikely that 
under the conditions of our experiments, there exist a 
signifi  cant number of inactive channels in the apical 
membrane. Thus, the failure to detect a decrease in sur-
face expression of ENaC after 30 min exposure to EGF 
despite the  30% decrease in Isc cannot be explained 
by a large pool of silent channels that obscures selective 
retrieval of a small number of active channels. Further-
more, we did observe a time-dependent decrease in 
ENaC surface expression at later time points (60, 90, 
and 120 min). Despite the fact that EGF-induced inhibi-
tion of sodium absorption is sensitive to mutations at 
sites associated with channel retrieval, our results dem-
onstrate that inhibition occurs without concurrent 
channel internalization.
Channel Open Probability (Po)
Since the  30% decrease in current elicited by EGF 
treatment occurs with no change in the apical surface 
expression of ENaC, the most likely mechanism for the 
fall in ENaC activity is a reduction in Po. Michlig et al. 
(2005) arrived at a similar conclusion based on studies 
of progesterone-induced inhibition of sodium current 
in oocytes expressing ENaC subunits. The rapid revers-
ibility of EGF-induced inhibition of Isc at early time points 
(<30 min; Fig. 11) is also consistent with reversible alter-
ations in channel gating rather than channel retrieval 
and degradation (Booth and Stockand, 2003). A recent 
study of wild-type and Liddle’s mutants expressed in 
MDCK cells found poor channel recycling of internal-
ized ENaC (Chen et al., 2007). Introduction of the 
β-S518K mutation (gating mutant with Po   1.0) did not 
prevent the early inhibition by EGF, indicating that the 
mechanism by which EGF inhibits ENaC is independent 
of the normal gating process that is altered by the S518K 
modifi  cation. In fact, the S518K mutant was inhibited to 
a greater degree than wild-type ENaC. If EGF-induced 
inhibition of ENaC function is due to protein modifi  ca-
tion of ENaC (e.g., subunit ubiquitination) resulting in 
channel inactivation, then an increase in fractional inhi-
bition would be predicted with the β-S518K mutation. 
ERK2 can phosphorylate C-terminal peptides from β- 
and γ-ENaC subunits (Shi et al., 2002a), and progester-
one-stimulated phosphorylation of β-ENaC is reduced 
by mutation of the putative ERK phosphorylation site in 
β-ENaC (T613A) (Michlig et al., 2005). It is unlikely that 
phosphorylation of ENaC per se is responsible for the 
ERK-dependent reduction in ENaC activity since muta-
tion of the adjacent PY motif (Y618A [Michlig et al., 
2005] and P616L [Fig. 6]) blocked progesterone and 
EGF-induced inhibition of sodium current. Additionally, 
it is improbable that the interaction of Nedd4-2 with 
ENaC alone results in a decrease with the Po of ENaC, 
since expression of a catalytically inactive mutant of 
Nedd4-2 (Michlig et al., 2005) prevented the progester-
one-induced decrease in ENaC activity, though pre-
sumably it should be capable of binding the channel. 326 Acute Downregulation of ENaC by EGF
Ubiquitination of the channel is a possible route by 
which open probability may be altered. The attachment 
of the fi  rst ubiquitin molecule involves the formation of 
a bond between ubiquitin’s C-terminal glycine and a ly-
sine residue on the target protein. Additional ubiquitin 
molecules can then be attached to the fi  rst through at-
tachment to one of three of its lysine residues: K29, K48, 
and K63 (Arnason and Ellison, 1994). A polyubiquitin 
chain consisting of four or more ubiquitin molecules at-
tached through K48 is a characteristic signal targeting 
proteins for degradation in the 26S proteasome (Thrower 
et al., 2000). Recently a ubiquitin-specifi  c protease, 
Usp2-45, was identifi  ed among the early gene products 
expressed in response to aldosterone in the mouse distal 
nephron. This protein can deubiquitinate ENaC, result-
ing in an increase in sodium absorption (Fakitsas et al., 
2007). The identifi   cation of new classes of ubiquitin 
binding proteins and deubiquitinating enzymes thought 
to be involved in the processing and regulation of inter-
nalization (Hicke and Dunn, 2003; Clague and Urbe, 
2006) add an additional level of complexity to the regu-
lation of ubiquitination.
Michlig et al. (2005) found from their studies of ENaC 
expressed in oocytes that progesterone caused an  80% 
reduction in sodium current with no signifi  cant change 
in ENaC surface expression and concluded that the pri-
mary effect was a decrease in channel Po (although Po 
was not directly measured). In contrast, we found that 
EGF caused a smaller reduction in sodium current 
( 30%) and after a delay of >30 min, surface expression 
of ENaC was reduced. This is consistent with an early de-
crease in channel Po (conclusion based on no detectable 
decrement in surface expression within 30 min after EGF 
treatment), though we have not measured Po directly. 
There are several possible explanations for why the sec-
ondary decrease in surface expression was observed in 
MDCK cells but not in oocytes. First, the mechanisms 
may be fundamentally different in oocytes and mamma-
lian epithelial cells. Second, a signifi  cant portion of the 
progesterone-induced decrease in sodium current may 
be ERK independent. EGF-simulated ERK1/2 phosphor-
ylation and inhibition of sodium absorption in mouse 
collecting duct cells and MDCK cells was rapid (5–15 
min) and completely blocked by treatment with an ERK 
kinase inhibitor. While progesterone has been shown to 
increase ERK phosphorylation at 6 and 12 h in oocytes 
(Nicod et al., 2002; Soundararajan et al., 2005), the pro-
gesterone-induced decrease in sodium current is nearly 
maximal at 30 min, and Frisov and coworkers did not 
show that progesterone-induced inhibition of sodium 
current was prevented by an ERK kinase inhibitor (Nicod 
et al., 2002; Michlig et al., 2005). Third, ENaC expression 
in oocytes results in delivery of a signifi  cant  fraction 
(90%) (Vallet et al., 2002) of inactive channels to the 
plasma membrane (i.e., channels that can be activated by 
extracellular trypsin), thus a correlation between changes 
in amiloride-sensitive current and biochemical estimates 
of surface expression may be tenuous.
In summary, our results are consistent with an ERK-
mediated decrease in channel Po and enhanced removal 
of ENaC from the apical membrane. The importance 
of the examination of ERK-mediated control of so-
dium absorption is twofold. First, in autosomal reces-
sive polycystic kidney disease, mislocalization of the EGF 
receptor to the apical membrane results in chronic ac-
tivation of ERK1/2 (Veizis and Cotton, 2005). The re-
sulting inhibition in sodium absorption is believed to 
contribute to disease progression (Omori et al., 2006). 
Second, although this study deals with the EGF-induced 
inhibition in ENaC activity, other agonists, including 
extracellular ATP and PMA (Falin et al., 2005), inhibit 
sodium absorption partially via an ERK-mediated mech-
anism and these results may aid in our understanding 
of those processes.
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